Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17967 | 573 | 48.8 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
584 | 3 | POMPE DISEASE//PIN1//CYCLOPHILIN | 15652 |
2159 | 2 | PIN1//CYCLOPHILIN//CALCINEURIN | 4989 |
17967 | 1 | PIN1//PPIASE//PARVULIN | 573 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PIN1 | authKW | 7081892 | 37% | 63% | 211 |
2 | PPIASE | authKW | 370337 | 5% | 24% | 29 |
3 | PARVULIN | authKW | 348791 | 2% | 55% | 12 |
4 | PIN 1 | authKW | 332027 | 2% | 69% | 9 |
5 | PIN1 INHIBITOR | authKW | 319735 | 1% | 100% | 6 |
6 | ESS1 | authKW | 274057 | 1% | 86% | 6 |
7 | PEPTIDYL PROLYL ISOMERASE | authKW | 216120 | 3% | 21% | 19 |
8 | STRUCT MED BIOCHEM | address | 200609 | 1% | 47% | 8 |
9 | MEDCANC BIOL PROGRAM | address | 186505 | 1% | 50% | 7 |
10 | MED HEMATOL ONCOLCANC BIOL PROGRAM | address | 179840 | 2% | 38% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1891 | 48% | 0% | 276 |
2 | Cell Biology | 1267 | 25% | 0% | 144 |
3 | Oncology | 430 | 16% | 0% | 91 |
4 | Biophysics | 398 | 10% | 0% | 60 |
5 | Chemistry, Medicinal | 77 | 4% | 0% | 24 |
6 | Medicine, Research & Experimental | 46 | 5% | 0% | 26 |
7 | Pathology | 31 | 3% | 0% | 16 |
8 | Genetics & Heredity | 24 | 4% | 0% | 24 |
9 | Neurosciences | 23 | 6% | 0% | 37 |
10 | Geriatrics & Gerontology | 18 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STRUCT MED BIOCHEM | 200609 | 1% | 47% | 8 |
2 | MEDCANC BIOL PROGRAM | 186505 | 1% | 50% | 7 |
3 | MED HEMATOL ONCOLCANC BIOL PROGRAM | 179840 | 2% | 38% | 9 |
4 | FUJIAN TRANSLAT CANC NEURODEGENERAT | 106578 | 0% | 100% | 2 |
5 | WAISMAN DEV DISABILITIES | 106578 | 0% | 100% | 2 |
6 | MOL CELL SCI | 98360 | 2% | 15% | 12 |
7 | MEDCANC BIOL PROGRAM HEMATOL ONCOL | 95918 | 1% | 60% | 3 |
8 | ELE ON MICROSCOPE S | 71051 | 0% | 67% | 2 |
9 | UW CARBONE COMPREHENS CANC | 71051 | 0% | 67% | 2 |
10 | PROJECT TEAM BK21 | 60015 | 2% | 9% | 13 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NATURE CELL BIOLOGY | 958 | 1% | 0% | 7 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 623 | 8% | 0% | 44 |
3 | MOLECULAR CELL | 612 | 1% | 0% | 8 |
4 | ONCOLOGY REPORTS | 521 | 2% | 0% | 10 |
5 | APOPTOSIS | 393 | 0% | 1% | 1 |
6 | ACS CHEMICAL BIOLOGY | 389 | 1% | 0% | 4 |
7 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 384 | 4% | 0% | 23 |
8 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 368 | 0% | 1% | 1 |
9 | STRUCTURE | 342 | 1% | 0% | 5 |
10 | BIOCHEMISTRY | 331 | 3% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIN1 | 7081892 | 37% | 63% | 211 | Search PIN1 | Search PIN1 |
2 | PPIASE | 370337 | 5% | 24% | 29 | Search PPIASE | Search PPIASE |
3 | PARVULIN | 348791 | 2% | 55% | 12 | Search PARVULIN | Search PARVULIN |
4 | PIN 1 | 332027 | 2% | 69% | 9 | Search PIN+1 | Search PIN+1 |
5 | PIN1 INHIBITOR | 319735 | 1% | 100% | 6 | Search PIN1+INHIBITOR | Search PIN1+INHIBITOR |
6 | ESS1 | 274057 | 1% | 86% | 6 | Search ESS1 | Search ESS1 |
7 | PEPTIDYL PROLYL ISOMERASE | 216120 | 3% | 21% | 19 | Search PEPTIDYL+PROLYL+ISOMERASE | Search PEPTIDYL+PROLYL+ISOMERASE |
8 | PEPTIDYL PROLYL CIS TRANS ISOMERASE NIMA INTERACTING 1 | 159867 | 1% | 100% | 3 | Search PEPTIDYL+PROLYL+CIS+TRANS+ISOMERASE+NIMA+INTERACTING+1 | Search PEPTIDYL+PROLYL+CIS+TRANS+ISOMERASE+NIMA+INTERACTING+1 |
9 | PROLYL ISOMERASE | 137174 | 2% | 23% | 11 | Search PROLYL+ISOMERASE | Search PROLYL+ISOMERASE |
10 | PEPTIDYL PROLYL CIS TRANS ISOMERASE | 123177 | 3% | 12% | 20 | Search PEPTIDYL+PROLYL+CIS+TRANS+ISOMERASE | Search PEPTIDYL+PROLYL+CIS+TRANS+ISOMERASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHOU, XZ , LU, KP , (2016) THE ISOMERASE PIN1 CONTROLS NUMEROUS CANCER-DRIVING PATHWAYS AND IS A UNIQUE DRUG TARGET.NATURE REVIEWS CANCER. VOL. 16. ISSUE 7. P. 463 -478 | 121 | 62% | 5 |
2 | MIN, SH , ZHOU, XZ , LU, KP , (2016) THE ROLE OF PIN1 IN THE DEVELOPMENT AND TREATMENT OF CANCER.ARCHIVES OF PHARMACAL RESEARCH. VOL. 39. ISSUE 12. P. 1609 -1620 | 85 | 74% | 0 |
3 | LU, ZM , HUNTER, T , (2014) PROLYL ISOMERASE PIN1 IN CANCER.CELL RESEARCH. VOL. 24. ISSUE 9. P. 1033 -1049 | 82 | 64% | 22 |
4 | LU, KP , ZHOU, XZ , (2007) THE PROLYL ISOMERASE PIN 1: A PIVOTAL NEW TWIST IN PHOSPHORYLATION SIGNALLING AND DISEASE.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 8. ISSUE 11. P. 904 -916 | 80 | 60% | 294 |
5 | LIOU, YC , ZHOU, XZ , LU, KP , (2011) PROLYL ISOMERASE PIN1 AS A MOLECULAR SWITCH TO DETERMINE THE FATE OF PHOSPHOPROTEINS.TRENDS IN BIOCHEMICAL SCIENCES. VOL. 36. ISSUE 10. P. 501 -514 | 73 | 53% | 127 |
6 | LEE, TH , PASTORINO, L , LU, KP , (2011) PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PIN1 IN AGEING, CANCER AND ALZHEIMER DISEASE.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 13. ISSUE . P. - | 86 | 50% | 53 |
7 | FINN, G , LU, KP , (2008) PHOSPHORYLATION-SPECIFIC PROLYL ISOMERASE PIN1 AS A NEW DIAGNOSTIC AND THERAPEUTIC TARGET FOR CANCER.CURRENT CANCER DRUG TARGETS. VOL. 8. ISSUE 3. P. 223-229 | 56 | 86% | 42 |
8 | YEH, ES , MEANS, AR , (2007) PIN1, THE CELL CYCLE AND CANCER.NATURE REVIEWS CANCER. VOL. 7. ISSUE 5. P. 381-388 | 61 | 69% | 126 |
9 | MOORE, JD , POTTER, A , (2013) PIN1 INHIBITORS: PITFALLS, PROGRESS AND CELLULAR PHARMACOLOGY.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 23. ISSUE 15. P. 4283-4291 | 50 | 75% | 35 |
10 | WANG, JZ , LIU, BG , ZHANG, Y , (2015) PIN1-BASED DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR BREAST CANCER.PHARMACOLOGICAL RESEARCH. VOL. 93. ISSUE . P. 28 -35 | 76 | 54% | 1 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 31685 | AGING NEUROEPIDEMIOL GRP//1 3 BIS 2 CHLOROETHYL 1 NITROSOUREA//AMYOTROPHIC LATERAL SCLEROSIS MORTALITY |
2 | 2873 | CYCLOPHILIN//PEPTIDYL PROLYL CIS TRANS ISOMERASE//IMMUNOPHILIN |
3 | 22610 | WWP1//WW DOMAIN//CKIP 1 |
4 | 5889 | P TEFB//CDK9//RNA POLYMERASE II |
5 | 24379 | NEK2//NIMA//NEK6 |
6 | 36462 | ZBP 89//ZNF148//BAK GENES |
7 | 361 | TAU//TAUOPATHY//PAIRED HELICAL FILAMENTS |
8 | 19492 | FBXW7//FBW7//FBXO7 |
9 | 34185 | FLIGHTLESS I//TTYH1//TTYH2 |
10 | 16420 | PEDIAT CHILDREN SURG//SOMATIC GENOME VARIATIONS//CELL CYCLE RE ENTRY |